XLRN
Envestnet Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,412
| Closed | -$3.17M | – | 3993 |
|
|
2021
Q3 | $3.17M | Buy |
18,412
+274
| +2% | +$47.2K | ﹤0.01% | 1800 |
|
|
2021
Q2 | $2.28M | Buy |
18,138
+398
| +2% | +$49.9K | ﹤0.01% | 1967 |
|
|
2021
Q1 | $2.41M | Buy |
17,740
+1,633
| +10% | +$221K | ﹤0.01% | 1832 |
|
|
2020
Q4 | $2.06M | Buy |
16,107
+1,036
| +7% | +$133K | ﹤0.01% | 1742 |
|
|
2020
Q3 | $1.7M | Buy |
15,071
+10,629
| +239% | +$1.2M | ﹤0.01% | 1714 |
|
|
2020
Q2 | $423K | Sell |
4,442
-513
| -10% | -$48.9K | ﹤0.01% | 2502 |
|
|
2020
Q1 | $445K | Sell |
4,955
-2,086
| -30% | -$187K | ﹤0.01% | 2318 |
|
|
2019
Q4 | $373K | Buy |
7,041
+1,227
| +21% | +$65K | ﹤0.01% | 2635 |
|
|
2019
Q3 | $230K | Buy |
5,814
+69
| +1% | +$2.73K | ﹤0.01% | 2807 |
|
|
2019
Q2 | $236K | Buy |
5,745
+422
| +8% | +$17.3K | ﹤0.01% | 2810 |
|
|
2019
Q1 | $248K | Sell |
5,323
-372
| -7% | -$17.3K | ﹤0.01% | 2721 |
|
|
2018
Q4 | $248K | Buy |
+5,695
| New | +$248K | ﹤0.01% | 2537 |
|
|
2018
Q3 | – | Sell |
-506
| Closed | -$25K | – | 2874 |
|
|
2018
Q2 | $25K | Sell |
506
-86
| -15% | -$4.25K | ﹤0.01% | 2377 |
|
|
2018
Q1 | $23K | Buy |
592
+33
| +6% | +$1.28K | ﹤0.01% | 2336 |
|
|
2017
Q4 | $24K | Sell |
559
-94
| -14% | -$4.04K | ﹤0.01% | 2493 |
|
|
2017
Q3 | $25K | Sell |
653
-2,654
| -80% | -$102K | ﹤0.01% | 2454 |
|
|
2017
Q2 | $101K | Buy |
3,307
+164
| +5% | +$5.01K | ﹤0.01% | 2132 |
|
|
2017
Q1 | $83K | Sell |
3,143
-688
| -18% | -$18.2K | ﹤0.01% | 2254 |
|
|
2016
Q4 | $98K | Sell |
3,831
-258
| -6% | -$6.6K | ﹤0.01% | 2190 |
|
|
2016
Q3 | $148K | Sell |
4,089
-159
| -4% | -$5.76K | ﹤0.01% | 2164 |
|
|
2016
Q2 | $144K | Buy |
4,248
+1,177
| +38% | +$39.9K | ﹤0.01% | 2269 |
|
|
2016
Q1 | $81K | Sell |
3,071
-367
| -11% | -$9.68K | ﹤0.01% | 2504 |
|
|
2015
Q4 | $168K | Buy |
3,438
+636
| +23% | +$31.1K | ﹤0.01% | 2129 |
|
|
2015
Q3 | $70K | Buy |
+2,802
| New | +$70K | ﹤0.01% | 2499 |
|